Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

NCT04624256 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Stage IIC Prostate Cancer AJCC v8

Interventions

PROCEDURE: Discussion
RADIATION: Hypofractionated Radiation Therapy
RADIATION: Hypofractionated Radiation Therapy
OTHER: Laboratory Biomarker Analysis
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]